Literature DB >> 23296397

Testing for improvement in prediction model performance.

Margaret Sullivan Pepe1, Kathleen F Kerr, Gary Longton, Zheyu Wang.   

Abstract

Authors have proposed new methodology in recent years for evaluating the improvement in prediction performance gained by adding a new predictor, Y, to a risk model containing a set of baseline predictors, X, for a binary outcome D. We prove theoretically that null hypotheses concerning no improvement in performance are equivalent to the simple null hypothesis that Y is not a risk factor when controlling for X, H0 : P(D = 1 | X,Y ) = P(D = 1 | X). Therefore, testing for improvement in prediction performance is redundant if Y has already been shown to be a risk factor. We also investigate properties of tests through simulation studies, focusing on the change in the area under the ROC curve (AUC). An unexpected finding is that standard testing procedures that do not adjust for variability in estimated regression coefficients are extremely conservative. This may explain why the AUC is widely considered insensitive to improvements in prediction performance and suggests that the problem of insensitivity has to do with use of invalid procedures for inference rather than with the measure itself. To avoid redundant testing and use of potentially problematic methods for inference, we recommend that hypothesis testing for no improvement be limited to evaluation of Y as a risk factor, for which methods are well developed and widely available. Analyses of measures of prediction performance should focus on estimation rather than on testing for no improvement in performance.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296397      PMCID: PMC3625503          DOI: 10.1002/sim.5727

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  38 in total

1.  Performance of common genetic variants in breast-cancer risk models.

Authors:  Sholom Wacholder; Patricia Hartge; Ross Prentice; Montserrat Garcia-Closas; Heather Spencer Feigelson; W Ryan Diver; Michael J Thun; David G Cox; Susan E Hankinson; Peter Kraft; Bernard Rosner; Christine D Berg; Louise A Brinton; Jolanta Lissowska; Mark E Sherman; Rowan Chlebowski; Charles Kooperberg; Rebecca D Jackson; Dennis W Buckman; Peter Hui; Ruth Pfeiffer; Kevin B Jacobs; Gilles D Thomas; Robert N Hoover; Mitchell H Gail; Stephen J Chanock; David J Hunter
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

2.  Integrating the predictiveness of a marker with its performance as a classifier.

Authors:  Margaret S Pepe; Ziding Feng; Ying Huang; Gary Longton; Ross Prentice; Ian M Thompson; Yingye Zheng
Journal:  Am J Epidemiol       Date:  2007-11-02       Impact factor: 4.897

Review 3.  Assessment of claims of improved prediction beyond the Framingham risk score.

Authors:  Ioanna Tzoulaki; George Liberopoulos; John P A Ioannidis
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

Review 4.  A comparison of goodness-of-fit tests for the logistic regression model.

Authors:  D W Hosmer; T Hosmer; S Le Cessie; S Lemeshow
Journal:  Stat Med       Date:  1997-05-15       Impact factor: 2.373

5.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

6.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

7.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

8.  Estimation and Comparison of Receiver Operating Characteristic Curves.

Authors:  Margaret Pepe; Gary Longton; Holly Janes
Journal:  Stata J       Date:  2009-03-01       Impact factor: 2.637

9.  Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.

Authors:  Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

10.  The potential of genes and other markers to inform about risk.

Authors:  Margaret S Pepe; Jessie W Gu; Daryl E Morris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

View more
  104 in total

1.  Comparison of lifestyle-based and traditional cardiovascular disease prediction in a multiethnic cohort of nonsmoking women.

Authors:  Nina P Paynter; Michael J LaMonte; JoAnn E Manson; Lisa W Martin; Lawrence S Phillips; Paul M Ridker; Jennifer G Robinson; Nancy R Cook
Journal:  Circulation       Date:  2014-08-25       Impact factor: 29.690

2.  Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study.

Authors:  Hua Wang; Anzari Atik; Tessandra Stewart; Carmen Ginghina; Patrick Aro; Kathleen F Kerr; John Seibyl; Danna Jennings; Poul Henning Jensen; Kenneth Marek; Min Shi; Jing Zhang
Journal:  Neurobiol Dis       Date:  2018-04-27       Impact factor: 5.996

3.  Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.

Authors:  Gina-Maria Pomann; Elizabeth M Sweeney; Daniel S Reich; Ana-Maria Staicu; Russell T Shinohara
Journal:  Stat Med       Date:  2015-05-04       Impact factor: 2.373

4.  The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases.

Authors:  S Rinaldi; M Santoni; G Leoni; I Fiordoliva; G Marcantognini; T Meletani; G Armento; D Santini; T Newsom-Davis; M Tiberi; F Morgese; M Torniai; M Bower; Rossana Berardi
Journal:  Support Care Cancer       Date:  2018-11-08       Impact factor: 3.603

5.  Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.

Authors:  Andreas M Hötker; Yousef Mazaheri; Ömer Aras; Junting Zheng; Chaya S Moskowitz; Tatsuo Gondo; Kazuhiro Matsumoto; Hedvig Hricak; Oguz Akin
Journal:  AJR Am J Roentgenol       Date:  2016-02-22       Impact factor: 3.959

6.  Cross-validation and hypothesis testing in neuroimaging: An irenic comment on the exchange between Friston and Lindquist et al.

Authors:  Philip T Reiss
Journal:  Neuroimage       Date:  2015-04-25       Impact factor: 6.556

7.  Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores.

Authors:  Ying Ding; Yi Liu; Qi Yan; Lars G Fritsche; Richard J Cook; Traci Clemons; Rinki Ratnapriya; Michael L Klein; Gonçalo R Abecasis; Anand Swaroop; Emily Y Chew; Daniel E Weeks; Wei Chen
Journal:  Genetics       Date:  2017-03-24       Impact factor: 4.562

8.  Concordance measure and discriminatory accuracy in transformation cure models.

Authors:  Yilong Zhang; Yongzhao Shao
Journal:  Biostatistics       Date:  2018-01-01       Impact factor: 5.899

9.  Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance.

Authors:  Peter M Burch; Warren E Glaab; Daniel J Holder; Jonathan A Phillips; John-Michael Sauer; Elizabeth G Walker
Journal:  Toxicol Sci       Date:  2017-03-01       Impact factor: 4.849

10.  Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up.

Authors:  Shanshan Li; Ozioma Okonkwo; Marilyn Albert; Mei-Cheng Wang
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.